Greet Van den Berghe

发表

Towards closed-loop glycaemic control.

Bart De Moor, Tom Van Herpe, Greet Van den Berghe, 2009, Best practice & research. Clinical anaesthesiology.

Muscle atrophy and preferential loss of myosin in prolonged critically ill patients*

Sarah Derde, Ilse Vanhorebeek, G. Van den Berghe, 2012, Critical care medicine.

Outcome benefit of intensive insulin therapy in the critically ill: Insulin dose versus glycemic control*

Miet Schetz, G. Van den Berghe, P. Ferdinande, 2003, Critical care medicine.

Intensive Insulin Therapy in Critically Ill Patients: NICE-SUGAR or Leuven Blood Glucose Target?

Miet Schetz, Dieter Mesotten, G. Van den Berghe, 2009 .

Insulin therapy for the critically ill patient.

G. Van den Berghe, Greet Van den Berghe, 2003, Clinical cornerstone.

Glycemic Targets and Approaches to Management of the Patient with Critical Illness

Dieter Mesotten, G. Van den Berghe, Greet Van den Berghe, 2012, Current Diabetes Reports.

Interventions for preventing critical illness polyneuropathy and critical illness myopathy.

G. Van den Berghe, B. de Jonghe, G. Hermans, 2009, The Cochrane database of systematic reviews.

Effect of intensive insulin therapy on insulin sensitivity in the critically ill.

G. Van den Berghe, T. Hansen, L. Langouche, 2007, The Journal of clinical endocrinology and metabolism.

Intensive Insulin Therapy in Mixed Medical/Surgical Intensive Care Units

Miet Schetz, G. Van den Berghe, R. Bouillon, 2006, Diabetes.

The application of Model Predictive Control to normalize glycemia of critically ill patients

Bert Pluymers, Niels Haverbeke, Niels Haverbeke, 2007, 2007 European Control Conference (ECC).

Acute outcomes and 1-year mortality of intensive care unit-acquired weakness. A cohort study and propensity-matched analysis.

Rik Gosselink, Dieter Mesotten, G. Van den Berghe, 2014, American journal of respiratory and critical care medicine.

Tight glycemic control protects the myocardium and reduces inflammation in neonatal heart surgery.

Bart Meyns, Ilse Vanhorebeek, Patrick Wouters, 2010, The Annals of thoracic surgery.

Guidelines for pre-operative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery.

Malte Kelm, Paolo Pelosi, Piotr Ponikowski, 2009, European heart journal.

[Guidelines on diabetes, pre-diabetes, and cardiovascular diseases].

Bengt Jönsson, Eberhard Standl, John Betteridge, 2007, Revista espanola de cardiologia.

Guidelines for the use and interpretation of assays formonitoring autophagy (3rd edition)

Sangeeta Khare, Xin Qi, Ying Wang, 2016 .

Analysis of healthcare resource utilization with intensive insulin therapy in critically ill patients*

G. Van den Berghe, D. Hilleman, K. Kesteloot, 2006, Critical care medicine.

Strict blood glucose control with insulin during intensive care after cardiac surgery: impact on 4-years survival, dependency on medical care, and quality-of-life.

Miet Schetz, G. Van den Berghe, Greet Van den Berghe, 2006, European heart journal.

Insufficient activation of autophagy allows cellular damage to accumulate in critically ill patients.

Jan Gunst, Sarah Derde, Ilse Vanhorebeek, 2011, The Journal of clinical endocrinology and metabolism.

Intensive insulin therapy in the medical ICU.

G. Van den Berghe, R. Bouillon, A. Wilmer, 2006, The New England journal of medicine.

Glycemic and nonglycemic effects of insulin: how do they contribute to a better outcome of critical illness?

Ilse Vanhorebeek, G. Van den Berghe, I. Vanhorebeek, 2005, Current opinion in critical care.

Emergency Department Crowding in Relation to In-hospital Adverse Medical Events: A Large Prospective Observational Cohort Study.

Sandra Verelst, G. Van den Berghe, S. Verelst, 2013, The Journal of emergency medicine.

Intensive insulin therapy protects the endothelium of critically ill patients.

Ilse Vanhorebeek, Kristin Skogstrand, G. Van den Berghe, 2005, The Journal of clinical investigation.

Optimal control of glycemia among critically ill patients.

G. Van den Berghe, R. Bouillon, Greet Van den Berghe, 2004, JAMA.

Contribution of circulating lipids to the improved outcome of critical illness by glycemic control with intensive insulin therapy.

Dieter Mesotten, G. Van den Berghe, J. Swinnen, 2004, The Journal of clinical endocrinology and metabolism.

Risks and benefits of nutritional support during critical illness.

G. Van den Berghe, Greet Van den Berghe, Yves Debaveye, 2006, Annual review of nutrition.

Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary

Peter Lindgren, Ilse Vanhorebeek, Silvia G Priori, 2007 .

Management of hyperglycemia in hospitalized patients in non-critical care setting: an endocrine society clinical practice guideline.

Mary T Korytkowski, Richard Hellman, Victor M Montori, 2012, The Journal of clinical endocrinology and metabolism.

Metabolic, endocrine, and immune effects of stress hyperglycemia in a rabbit model of prolonged critical illness.

G. Van den Berghe, C. Mathieu, A. Giulietti, 2003, Endocrinology.

Clinical review: Consensus recommendations on measurement of blood glucose and reporting glycemic control in critically ill adults

Roman Hovorka, Thomas Desaive, Jean-Charles Preiser, 2013, Critical Care.

Reducing mortality in sepsis: new directions

Djillali Annane, Edward Abraham, G. Van den Berghe, 2002, Critical care.